Valve Selection in End-Stage Renal Disease: Should It Always Be Biological? Matthew L. Williams, MD, Joseph E. Bavaria, MD, Michael A. Acker, MD, Nimesh D. Desai, MD, Prashanth Vallabhajosyula, MD, W. Clark Hargrove, MD, Pavan Atluri, MD, Wilson Y. Szeto, MD The Annals of Thoracic Surgery Volume 102, Issue 5, Pages 1531-1535 (November 2016) DOI: 10.1016/j.athoracsur.2016.04.092 Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Survival in patients with end-stage renal disease younger than 65 years after valve replacement. The Annals of Thoracic Surgery 2016 102, 1531-1535DOI: (10.1016/j.athoracsur.2016.04.092) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Survival in patients with end-stage renal disease after valve replacement, stratified by endocarditis. The Annals of Thoracic Surgery 2016 102, 1531-1535DOI: (10.1016/j.athoracsur.2016.04.092) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions